Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
Sleep abnormality in neuromyelitis optica spectrum disorder.
Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies.
Impaired toll-like receptor 8 signaling in multiple sclerosis.
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
β-Arrestins 1 and 2 are critical regulators of inflammation.
Multiple sclerosis : A multielement survey.
Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes.
(+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats.
Validity of the diagnostic criteria for chronic cerebrospinal venous insufficiency and association with multiple sclerosis.
Expression and localization of aquaporin-4 in sensory ganglia.
Prior regular exercise improves clinical outcome and reduces demyelination and axonal injury in experimental autoimmune encephalomyelitis.
Multiple sclerosis severity and concern about falling: Physical, cognitive and psychological mediating factors.
Neuromyelitis optica spectrum disorder and varicella-zoster infection.
The temporal dynamics of visual processing in multiple sclerosis.
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.
Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.
Home functioning profiles in people with multiple sclerosis and their relation to disease characteristics and psychosocial functioning.
Refractory acute disseminated encephalomyelitis with anti-galactocerebroside antibody.
Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation.
Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis.
Pragmatic exercise intervention in people with mild to moderate multiple sclerosis: A randomised controlled feasibility study.
Accelerated Axonal Loss Following Acute CNS Demyelination in Mice Lacking Protein Tyrosine Phosphatase Receptor Type Z.
Cognitive reserve in ageing and Alzheimer's disease.
Pages
« first
‹ previous
…
406
407
408
409
410
411
412
413
414
…
next ›
last »